ArticleBulletin of mathematical biology2026
Coupled SDE-ODE Modeling of Tumor-Immune Dynamics to Infer Biomarker Release.
Article in Bulletin of mathematical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- How optimal control of cellular cost shapes population-level tumor growth dynamics.bioRxiv : the preprint server for biology · 2026Article
- Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.BMC cancer · 2026Article
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Tumor-immune interactions are central to cancer progression and treatment response, driving cell death through immune-mediated killing and resource-limited competition. In early-stage disease or following effective treatment, cancer populations are often small and difficult to observe directly. Disease monitoring therefore relies on the detection of biomarkers such as circulating tumor DNA (ctDNA) as noisy proxies to cancer size. Existing approaches lack robust frameworks to infer tumor burden from these signals when populations approach detection thresholds. We present a coupled deterministic-stochastic framework that links tumor-immune dynamics to biomarker release. A two prey, one predator Lotka-Volterra model captures interactions between immune cells and competing tumor subpopulations under shared resource constraints. Biomarker production is modeled using stochastic differential equations driven by tumor cell death arising from immune-mediated apoptosis and intratumor competition-induced necrosis. We incorporate both square-root (CIR-type) noise, representing count-limited fluctuations near the detection limit, and multiplicative (geometric-type) noise, representing proportional variability at higher concentrations. Within this framework, we derive analytical expressions for biomarker trajectories and first-passage statistics, including mean detection times under minimal detection thresholds. Our results demonstrate how tumor heterogeneity, immune pressure, and stochastic variance structure jointly shape biomarker emergence, persistence, and detectability. Together, this work provides a mechanistically interpretable and mathematically tractable foundation for inferring tumor burden from noisy biomarker signals across clinically relevant concentration regimes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.